Apr 12 |
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
|
Apr 11 |
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why
|
Apr 5 |
Praxis Precision Medicines to Participate in Upcoming April Conferences
|
Mar 29 |
Health Care Roundup: Market Talk
|
Mar 28 |
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
|
Mar 28 |
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
|
Mar 27 |
Praxis Precision Medicines announces proposed public offering
|
Mar 27 |
Praxis (PRAX) Surges on Positive Epilepsy Study Results
|
Mar 26 |
Praxis: 2nd Half 2024 ET Readout Could Lead To U.S. Regulatory Filing
|
Mar 26 |
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
|